ARTICLE | Company News
FDA accepts Barrier's Sebazole NDA
December 10, 2005 2:44 AM UTC
FDA accepted for filing an NDA from BTRX for Sebazole topical gel formulation of 2% ketoconazole to treat seborrheic dermatitis. The company submitted the application in September. On Friday, BTRX was...